YCCI News

Yale School of Medicine was an early adopter of telemedicine technology, and it has made a major difference in safely reaching patients and clinical trial participants during social distancing.

Manisha Juthani, MD, has been a central figure both at Yale and as an advisor to government officials during the effort to subdue the COVID-19 pandemic.

The game prompts students to practice navigating peer pressure situations involving vaping. By encouraging teens to use their own voices in simulated situations, the researchers hoped they would become better prepared to face real-world scenarios.

YCCI's internship is an opportunity for young people to be exposed to careers in fields that were never meaningfully suggested to them before. It also is part of a long-term national health care priority: to create a health system where patients of color are more frequently treated by health professionals who look like them.

The study found that giving higher doses of buprenorphine in EDs may provide a longer period of relief to people after they are discharged, which may help them navigate barriers to access to follow-up care before they experience withdrawal symptoms.

Yale researchers have found a protein that acts like a detergent to wipe out invading pathogens much like the way that Ajax cleans dirty dishes or sanitizes a kitchen countertop.

A new study from the Yale School of Public Health suggests that a promising early intervention targeted at spousal care partners not only increases their quality of life but also may positively impact their partners living with dementia.

Dr. Marcella Nunez-Smith ensuring equitable COVID response for all communities

In a new study, Yale researchers show that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. The findings are published July 5 in the journal Neuron.